Pathogenic mechanisms of depression in multiple sclerosis

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 23, Issue 3, 2011, Pages 261-276

  Vattakatuchery, Joe John ^a   Rickards, Hugh ^b   Cavanna, Andrea Eugenio ^c  

^a 5 Boroughs Partnership NHS Trust   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON BETA SERINE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; ARTICLE; AUTOIMMUNE DISEASE; BRAIN DAMAGE; CLINICAL TRIAL; DEPRESSION; HUMAN; IATROGENIC DISEASE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; SUICIDE ATTEMPT;

EID: 80054968135     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/jnp.23.3.jnp261     Document Type: Article

References (77)

1. Turner AP, Williams RM, Bowe JD, et al: Suicidal ideation and multiple sclerosis. Arch Phys Med Rehabil 2006; 87: 1073-1077
2. Moore AC, MacLeod AK, Barnes D, et al: Future thinking and depression in relapsing-remitting multiple sclerosis. Br J Health Psychol 2006; 11:663-675
3. Charcot JM: Lectures on Diseases of the Nervous System, delivered at La Salpetriere. London, UK, New Sydenham Society, 1887, p 194-195
4. José M: Psychological aspects of multiple sclerosis. Clin Neu-rol Neurosurg 2008; 110:868-877
5. Minden SL, Schiffer RB: Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol 1990; 47:98-104
6. Wallin MT, Wilken JA, Turner AP, et al: Depression and multiple sclerosis: review of a lethal combination. J Rehab Res Dev 2006; 43:45-62
7. Sadovnick AD, Remick RA, Allen J, et al: Depression and multiple sclerosis. Neurology 1996; 46:628-632
8. Chwastiak L, Ehde DM, Gibbons LE, et al: Depressive symptoms and severity of illness in multiple sclerosis: epidemio-logic study of a large community sample. Am J Psychiatry 2002; 159:1862-1868
9. Rickards H: Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke. J Neurol Neurosurg Psychiatry 2005; 76:i48-i52
10. Lester K, Stepleman L, Hughes M: The association of illness severity, self reported cognitive impairment, and perceived illness-management with depression and anxiety in a multiple sclerosis clinic population. J Behav Med 2007; 30:177-186
11. Sadovnick AD, Eisen K, Paty DW, et al: Cause of death in patients attending multiple sclerosis clinics. Neurology 1991; 41:1193-1196
12. Feinstein A: An examination of suicide intent in patients with multiple sclerosis. Neurology 2002; 59:674-678
13. Barbellion WNP: The Journal of a Disappointed Man. London, UK, Chatto and Windus, 1919
14. Pommé B, Girard J, Planche R: Forme depressive de début d'une sclerosis en plaques. Ann Med Psychol 1963; 121:133
15. O' Malley PP: Severe mental symptoms in disseminated sclerosis: a neuropathological study. J Irish Med Ass 1966; 55:115-127
16. Young AC, Saunders J, Ponford JR: Mental change as an early feature of multiple sclerosis. J Neurol Neurosurg Psychiatry 1976; 39:1008-1013
17. Zarei M: Clinical characteristics of cortical multiple sclerosis. J Neurol Sci 2006; 245:53-58
18. Whitlock FA, Siskind MM: Depression as a major symptom of multiple sclerosis. J Neurol Neurosurg Psychiatry 1980; 43: 861-865
19. Sullivan MJL, Weinshenker B, Mikail S, et al: Depression before and after diagnosis of multiple sclerosis. Multiple Sclerosis 1995; 1:104-108
20. Wallin MT, Wilken JA, Turner AP, et al: Depression and multiple sclerosis: review of a lethal combination. J Rehab Res Dev 2006; 43:45-62
21. Schiffer RB, Caine ED, Bamford KA, et al: Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 1983; 140: 1498-1500
22. Rabins PV, Benjamin RB, O' Donell P, et al: Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986; 109:585-597
23. Honer WG, Hurwitz T, Li DKB, et al: Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol 1987; 44:187-190
24. Reischies FM, Baum K, Brau H, et al: Cerebral magnetic resonance imaging findings in multiple sclerosis. Arch Neurol 1988; 45:1114-1116
25. Berg D, Supprian T, Thomas J, et al: Lesion patterns in patients with multiple sclerosis and depression. Multiple Sclerosis 2000; 6:156-162
26. Bakshi R, Czarnecki D, Shaikh ZA, et al: Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Brain Imag 2000; 11:1153-1158
27. Pujol J, Bello J, Deus J, et al: Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997; 49:1105-1110
28. Pujol J, Bello J, Deus J, et al: Beck Depression Inventory factors related to demyelinating lesions of the left arcuate fasciculus region. Psychiatr Res 2000; 99:151-159
29. Zorzon M, de Masi R, Nasuelli D, et al: Depression and anxiety in multiple sclerosis: a clinical and MRI study in 95 subjects. J Neurol 2001; 248:416-421
30. Feinstein A, Roy P, Lobaugh N, et al: Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62:586-590
31. Feinstein A, O'Connor P, Akbar N, et al: Diffuse tensor imaging abnormalities in depressed multiple sclerosis patients. Multiple Sclerosis 2010; 16:189-196
32. Sabatini U, Pozzilli C, Pantano P, et al: Involvement of the limbic system in multiple sclerosis patients with depressive disorders. Biol Psychiatry 1996; 39:970-975
33. Korf J, Klein HC, Versijpt J, et al: Considering depression as a consequence of activation of the inflammatory response system. Acta Neuropsychiatr 2002; 14:1-10
34. Gold SM, Irwin MR: Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. Neurol Clin 2006; 24:507-519
35. Thomas AJ, Ferrier IN, Kalaria RN, et al: Evaluation in late-life depression of intercellular adhesion molecule-1 expression in the dorsal prefrontal cortex. Am J Psychiatry 2000; 157:1682-1684
36. Lanquillon S, Krieg JC, Bening-Abu-Sach U, et al: Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22:370-379
37. Cavanagh J, Mathias C: Inflammation and its relevance to psychiatry. Adv Psychiatr Treat 2008; 14:248-255
38. Foley FW, Miller AH, Traugott U, et al: Psychoimmunological dysregulation in multiple sclerosis. Psychosomatics 1988; 29: 398-403
39. Foley FW, Traugott U, LaRocca NG, et al: A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol 1992; 49:238-244
40. Fesselbender K, Schmidt R, Mofsner R, et al: Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 1998; 55:66-72
41. Mohr DC, Goodkin DE, Islar J, et al: Treatment of depression is associated with suppression of non-specific and antigen-specific TH1 responses in multiple sclerosis. Arch Neurol 2001; 58:1081-1086
42. Kahl KG, Kruse N, Faller H, et al: Expression of tumor necrosis factor-a and interferon-7 mRNA in blood cells correlates with depression scores during an attack in patients with multiple sclerosis. Psychoneuroendocrinology 2002; 27:671-681
43. Loftis JM, Hauser P: The phenomenology and treatment of interferon-induced depression. J Affect Disord 2004; 82:175-190
44. Myint AM, Schwarz MJ, Steinbusch HWM, et al: Neuropsy-chiatric disorders related to interferon and interleukins treatment. Metab Brain Dis 2009; 24:55-68
45. Klapper JA: Interferon-beta treatment of multiple sclerosis. Neurology 1994; 44:188
46. Neilley LK, Goodin DS, Goodkin DE, et al: Side-effect profile of interferon j3-1b in MS: results of an open-label trial. Neurology 1996; 46:552-554
47. European Study Group on IFN-j3-1b in secondary-progressive MS: placebo-controlled multicentre randomised trial of inter-feron-j3-1b in treatment of secondary-progressive multiple sclerosis. Lancet 1998; 352:1491-1497
48. Borras C, Rio J, Porcel J, et al: Emotional state of patients with relapsing-remitting MS treated with interferon j3-1b. Neurology 1999; 52:1636-1639
49. Mohr DC, Likosky W, Dwyer P, et al: Course of depression during the initiation of interferon j3-1a treatment for multiple sclerosis. Arch Neurol 1999; 56:1263-1265
50. Patten SB, Metz LM: Interferon /31a and depression in secondary-progressive MS: data from SPECTRIMS trial. Neurology 2003; 59:744-746
51. Feinstein A, O'Connor P, Feinstein K: Multiple sclerosis, interferon j3-1b, and depression: a prospective investigation. J Neurol 2002; 249:815-820
52. Zephir H, De Seze J, Stojkovic T, et al: Multiple sclerosis and depression: influence of interferon-/} therapy. Multiple Sclerosis 2003; 9:284-288
53. Pattern SB: Depressive symptoms in a treated multiple sclerosis cohort. Multiple Sclerosis 2003; 9:616-620
54. Feinstein A: Multiple sclerosis, disease-modifying treatments, and depression: a critical methodological review. Multiple Sclerosis 2000; 6:343-348
55. Walther EU, Hohlfeld R: Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999; 53:1622-1627
56. Mohr DC, Goodkin DE, Gatto N, et al: Depression, coping, and level of neurological impairment in multiple sclerosis. Multiple Sclerosis 1997; 3:254-258
57. Janssens ACJW, Van Doorn PA, de Boer JB, et al: Impact of recently-diagnosed multiple sclerosis on quality of life, anxiety, depression, and distress of patients and partners. Acta Neurol Scand 2003; 108:389-395
58. Janssens ACJW, Buljevac D, Van Doorn PA, et al: Prediction of anxiety and distress following diagnosis of multiple sclerosis: a two-year longitudinal study. Multiple Sclerosis 2006; 12: 794-780
59. Tsivgoulis G, Triantafyllou N, Papageorgiou C, et al: Associations of the Expanded Disability Status Scale with anxiety and depression in multiple sclerosis outpatients. Acta Neurol Scand 2007; 115:67-72
60. Nerenz DR, Leventhal H: Self-regulation theory in chronic illness, in Coping With Chronic Disease. Edited by Burish TG, Bradley LA. New York, Academic Press, 1983, pp 13-37
61. Bishop GD, Briede C, Cavazos L, et al: Processing illness information: the role of disease prototypes. Basic Appl Soc Psychol 1987; 8:21-44
62. Schiaffino KM, Shawaryn MA, Blum D: Examining the impact of illness representations on psychological adjustment to chronic illnesses. Health Psychol 1998; 17:262-268
63. Jopson NM, Moss-Morris R: The role of illness severity and illness representations in adjusting to multiple sclerosis. J Psy-chosom Res 2003; 54:503-511
64. Vuger-Kovacic D, Gregurek R, Kovacic D, et al: Relationship between anxiety, depression, and locus of control of patients with multiple sclerosis. Multiple Sclerosis 2007; 13:1065-1067
65. Abramson LY, Matasky GI, Alloy LB: Hopelessness depression: a theory-based subtype of depression. Psychol Rev 1989; 96:358-372
66. Kneebone II, Dunmore E: Attributional style and symptoms of depression in persons with multiple sclerosis. Int J Behav Med 2004; 11:110-115
67. Moore AC, MacLeod AK, Barnes D, et al: Future thinking and depression in relapsing-remitting multiple sclerosis. Br J Health Psychol 2006; 11:663-675
68. Shnek ZM, Foley FW, LaRocca NG, et al: Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 1997; 19:287-294
69. Sadovnick AD, Remick RA, Allen J, et al: Depression and multiple sclerosis. Neurology 1996; 46:628-632
70. Siegert RJ, Abernethy DA: Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76:469-475
71. Feinstein A: Mood disorders in multiple sclerosis and effects on cognition. J Neurol Sci 2006; 245:63-66
72. Rickards H: Depression in neurological disorders: an update. Curr Opin Psychiatry 2006; 19:294-298
73. Schiffer RB, Winemann NM: Antidepressant pharmacology of depression associated with multiple sclerosis. Am J Psychiatry 1990; 147:1493-1497
74. Scott TF, Nussbaum P, McConnell H, et al: Measurement of treatment response to sertraline in depressed multiple sclerosis using the Carroll Scale. Neurol Res 1995; 17:421-422
75. Corruble E, Awad H, Chouinard G, et al: ECT in delusional depression with multiple sclerosis. Am J Psychiatry 2004; 161: 1715
76. Sallom AC, Kneebone II: Treatment of depression in people who have multiple sclerosis. Multiple Sclerosis 2007; 13:632-635
77. Paparrigopoulos T, Ferentinos P, Kouzoupis A, et al: The neu-ropsychiatry of multiple sclerosis: focus on disorders of mood, affect, and behaviour. Int Rev Psychiatry 2010; 22:14-21